ctrl K

Watchlist Price Alert

Drugs Made In America Acq... (DMAA)

NASDAQ: DMAA · Real-Time Price · USD

10.09

-0.01 (-0.10%)

At close: May 07, 2025, 11:32 AM

Drugs Made In America Acquisition Ordinary Shares Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-145.26K	-144.98K	-54.93
Interest Income	n/a	n/a	n/a
Pretax Income	-145.26K	-144.98K	-54.93
Net Income	-145.26K	-144.98K	-54.93
Selling & General & Admin	145.26K	144.98K	54.93
Research & Development	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a
Operating Expenses	145.26K	144.98K	54.93
Interest Expense	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	-144.59K	-144.87K	54.93
Income Tax Expense	n/a	n/a	n/a
Shares Outstanding (Basic)	8.57K	8.57K	8.57K
Shares Outstanding (Diluted)	8.57K	8.57K	8.57K
EPS (Basic)	-0.04	-0.01	-0.01
EPS (Diluted)	-0.04	-0.01	-0.01
EBITDA	-144.93K	-144.93K	n/a
EBIT	-145.26K	-144.98K	-54.93
Depreciation & Amortization	334.81	54.93	54.93